Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa

Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa

Recombinant porcine factor VIII (rpFVIII) is indicated for treating bleeding episodes in acquired haemophilia A, but there are few data regarding laboratory methods to adequately monitor treatment. This study involving three Italian laboratories aimed to evaluate the analytical performance of differ...

Full description

Bibliographic Details
Main Authors:	Cristina Novembrino, Ilaria Quaglia, Angelo Claudio Molinari, Alessandra Borchiellini, Antonio Coppola, Rita Carlotta Santoro, Massimo Boscolo-Anzoletti, Eleonora Galbiati, Ezio Zanon, Alessandra Valpreda
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Diagnostics
Subjects:	acquired haemophilia A recombinant porcine FVIII assay methods
Online Access:	https://www.mdpi.com/2075-4418/12/8/1999

Similar Items

FREQUENCY AND LEVELS OF FACTOR EIGHT INHIBITORS IN KNOWN HAEMOPHILIACS
by: Mumtaz Amir, et al.
Published: (2018-08-01)

Diagnosis and Management of Post-Partum Hemorrhage Caused by Acquired Hemophilia A: A Case Report
by: Nawshirwan G. Rashid, et al.
Published: (2022-06-01)

Liposomal factor VIII as an efficient pharmaceutical system for the treatment of hemophilia
by: Maryam Karimi, et al.
Published: (2024-06-01)

Efficacy of Replacement and Anti-Platelet Therapies in a Patient with Severe Haemophilia A Undergoing Percutaneous Coronary Stent Implantation
by: Dorina Cultrera, et al.
Published: (2022-07-01)

Analysis of the correlation between body weight, body composition, and factor VIII recovery in paediatric patients with severe haemophilia A – a single-centre study
by: Katarzyna Koch, et al.
Published: (2023-09-01)

A case of idiopathic acquired haemophilia - A with massive subcutaneous bleeding
by: Sunil Raviraj Kothakota, et al.
Published: (2021-01-01)

Switching from Sucrose-Formulated rFVIII to Octocog Alfa (BAY 81-8973) Prophylaxis Improves Bleed Outcomes in the LEOPOLD Clinical Trials
by: Kenet G, et al.
Published: (2023-06-01)

Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice
by: Tischer B, et al.
Published: (2018-03-01)

Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects
by: Raimondo De Cristofaro, et al.
Published: (2019-04-01)

Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
by: Valentina Lorenzoni, et al.
Published: (2018-08-01)

Atypical Presenting Symptoms of Acute Onset Acquired Haemophilia with Eosinophilic Fasciitis
by: Yuto Nakakubo, et al.
Published: (2020-06-01)

The changing landscape of treatment for acquired hemophilia A
by: Massimo Franchini, et al.
Published: (2025-01-01)

Navigating challenges in diagnosing acquired hemophilia A: A case report from Syria
by: Oubai Nayouf, et al.
Published: (2024-05-01)

Acquired Factor VIII Inhibitors: Three Cases
by: Tay Za Kyaw, et al.
Published: (2013-03-01)

Emicizumab in two patients with acquired haemophilia A – case report
by: Zhao Milly, et al.
Published: (2024-08-01)

Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases
by: E. Mauro, et al.
Published: (2019-04-01)

Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life
by: Ilaria Nichele, et al.
Published: (2024-04-01)

The intriguing association between cancer and congenital bleeding disorders
by: Ezio Zanon
Published: (2024-12-01)

Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective
by: Daniela Paola Roggeri, et al.
Published: (2020-06-01)

Managing Relevant Clinical Conditions of Hemophilia A/B Patients
by: Massimo Morfini, et al.
Published: (2023-06-01)

Acquired haemophilia: a case report and a clinical review
by: Lucia Todaro, et al.
Published: (2013-04-01)

Acquired Haemophilia A: A Review of What We Know
by: Mingot-Castellano ME, et al.
Published: (2022-11-01)

Acquired Hemophilia A Associated with NSAID: A Case Report
by: Diane Lukito Setiawan, et al.
Published: (2019-11-01)

Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
by: Pearce Michael I, et al.
Published: (2011-10-01)

Haemophilic arthropathy
by: Sarath Chandra Mouli, et al.
Published: (2014-10-01)

Flow-Cytometry Platform for Intracellular Detection of FVIII in Blood Cells: A New Tool to Assess Gene Therapy Efficiency for Hemophilia A
by: Muhammad Elnaggar, et al.
Published: (2020-06-01)

Real pandemic world results of pharmacokinetic-tailored personalized prophylaxis of bleeds in Polish children and adolescents with severe hemophilia A
by: Tomasz Urasiński, et al.
Published: (2023-02-01)

Spontaneous Spinal Epidural Haematoma Secondary to Autoimmune Acquired Haemophilia
by: Fardad T. Afshari, et al.
Published: (2018-12-01)

A case report of laryngeal haemorrhage as a rare presenting complaint for acquired haemophilia
by: Mohamed El-Amin, et al.
Published: (2020-09-01)

An unexpected turn of events: A rare case of Acquired Haemophilia A after a violin spider bite
by: Caterina Zattera, et al.
Published: (2022-06-01)

Three-Decade Successive Establishment of Care for Women/Girls from Families with Haemophilia
by: Chuansumrit A, et al.
Published: (2022-10-01)

Comparison of perioperative practices for placement of central venous access devices (CVAD) in children with haemophilia
by: Kwan Celia, et al.
Published: (2022-09-01)

Growing weapons to fight hemophilia
by: Pier Mannuccio Mannucci
Published: (2023-02-01)

Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
by: Linari S, et al.
Published: (2020-05-01)

Serum Concentrations of Vitamin D, Calcium, Phosphorus and Trace Minerals in Adults and Children with Haemophilia A: Association with Disease Severity, Quality of Life, Joint Health and Functional Status
by: Amir Abbasnezhad, et al.
Published: (2020-01-01)

Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients
by: Yael Lichter, et al.
Published: (2021-11-01)

Acquired hemophilia A: A case report
by: Sarita Pradhan, et al.
Published: (2017-01-01)

Past, present and future of hemophilia: a narrative review
by: Franchini Massimo, et al.
Published: (2012-05-01)

Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits
by: Mario Schiavoni, et al.
Published: (2019-12-01)

Severe Recurrent Achalasia Cardia Responding to Treatment of Severe Autoimmune Acquired Haemophilia
by: H. Al-Jafar, et al.
Published: (2012-09-01)